Skip to main content
. 2016 Sep 10;7(42):68734–68748. doi: 10.18632/oncotarget.11930

Table 1. SNP haplotypes, methylation and expression/splicing status of DUSP22 and its paralog.

DUSP22 (6p25.3) 16p11.2 paralog
SNPs alleles
  rs11242812 G A
  rs1129085 G and/or A G
  rs1046656 C T
Methylation status (5′ CpG island) No methylation$($ in normal tissues & tested PTCL cases) Methylated ( if not deleted in the 5′ region)
Expression Expressed in normal tissues& PTCL without 6p25.3 rearrangement Silenced in PTCL with 6p25.3 break Completely silent or hypomorphic
Isoforms Alternative mRNA splicing Not detected (expression absent or very weak)
Regular splicing, 8 coding exons Protein: 184 a.a. Expressed at the RNA level in PBL Silenced in PTCL with 6p25.3 break Not detected
Intron 7 not spliced, leading to alternative reading frame, exon 8 then being in the 3′ UTR Predicted protein: 205 a.a., p.A170fs37* Predominant in normal PBL Silenced in PTCL with 6p25.3 break Not detected
Exon 4 spliced, leading to frameshift Predicted protein: 54 a.a., p.G47fs9* Expressed at the RNA level in PBL Silenced in PTCL with 6p25.3 break Not detected at the protein level Not detected

Legends: The SNP haplotypes, methylation and expression status of DUSP22 and its 16p11.2 are summarized here. For isoforms, the splicing events and the predicted consequence at the protein levels (number of amino acids -a. a.- and when there is a alternative reading frame, position of the first amino acid affected by frameshift –fs-, and number of alternative amino acids before the STOP codon -*-). UTR, untranslated region; PTCL, peripheral T-cell lymphomas; PBL, normal peripheral blood lymphocytes.